Schroder UK Public Private Trust plc announces that Susan Searle, Chair of the Company since 2015, has retired following the Company's Annual General Meeting on 4 June 2021, in line with the Company's published succession plan. Tim is currently the chair of Storm Therapeutics Ltd, Karus Therapeutics Ltd. and Modulus Oncology Ltd, a director of AstronauTx Ltd. and an independent non-executive director of Record plc. Previously, Tim was a member of the governing board of InnovateUK, the UK's innovation agency, a director of the UK Cell and Gene Therapy Catapult and chair of the UK BioIndustry Association.